Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52


A "Pathology Explanation Clinic (PEC)" for Patient-Centered Laboratory Medicine Test Results.

Gibson B, Bracamonte E, Krupinski EA, Briehl MM, Barker GP, Weinstein JB, Weinstein RS.

Acad Pathol. 2018 Mar 19;5:2374289518756306. doi: 10.1177/2374289518756306. eCollection 2018 Jan-Dec.


Spatial distribution of uranium in mice kidneys detected by laser ablation inductively coupled plasma mass spectrometry.

Jim V, LaViolette C, Briehl MM, Ingram JC.

J Appl Bioanal. 2017 Jun;3(3):43-48. doi: 10.17145/jab.17.007.


Second Flexner Century: The Democratization of Medical Knowledge: Repurposing a General Pathology Course Into Multigrade-Level "Gateway" Courses.

Weinstein RS, Waer AL, Weinstein JB, Briehl MM, Holcomb MJ, Erps KA, Holtrust AL, Tomkins JM, Barker GP, Krupinski EA.

Acad Pathol. 2017 Jul 18;4:2374289517718872. doi: 10.1177/2374289517718872. eCollection 2017 Jan-Dec.


Flexner 2.0-Longitudinal Study of Student Participation in a Campus-Wide General Pathology Course for Graduate Students at The University of Arizona.

Briehl MM, Nelson MA, Krupinski EA, Erps KA, Holcomb MJ, Weinstein JB, Weinstein RS.

Acad Pathol. 2016 Dec 17;3:2374289516680217. doi: 10.1177/2374289516680217. eCollection 2016 Jan-Dec.


Weaving the Web: Evaluation Strategies to Help Native-American Undergraduate Research Training Programs Navigate Students to Success.

Laurila K, Ingram JC, Briehl MM, Trotter RT 2nd.

CURQ Web. 2015 Spring;35(3):4-11. No abstract available.


Oxygen in human health from life to death--An approach to teaching redox biology and signaling to graduate and medical students.

Briehl MM.

Redox Biol. 2015 Aug;5:124-139. doi: 10.1016/j.redox.2015.04.002. Epub 2015 Apr 11. Review.


Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.

Jaramillo MC, Briehl MM, Batinic-Haberle I, Tome ME.

Free Radic Biol Med. 2015 Jun;83:89-100. doi: 10.1016/j.freeradbiomed.2015.01.031. Epub 2015 Feb 26.


Mitochondria and redox homoeostasis as chemotherapeutic targets.

Briehl MM, Tome ME, Wilkinson ST, Jaramillo MC, Lee K.

Biochem Soc Trans. 2014 Aug;42(4):939-44. doi: 10.1042/BST20140087. Review.


Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.

Barr PM, Miller TP, Friedberg JW, Peterson DR, Baran AM, Herr M, Spier CM, Cui H, Roe DJ, Persky DO, Casulo C, Littleton J, Schwartz M, Puvvada S, Landowski TH, Rimsza LM, Dorr RT, Fisher RI, Bernstein SH, Briehl MM.

Blood. 2014 Aug 21;124(8):1259-65. doi: 10.1182/blood-2014-04-570044. Epub 2014 Jul 11.


The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma.

Lee K, Hart MR, Briehl MM, Mazar AP, Tome ME.

Int J Oncol. 2014 Jul;45(1):439-47. doi: 10.3892/ijo.2014.2396. Epub 2014 Apr 23.


Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.

Gustafson HL, Yao S, Goldman BH, Lee K, Spier CM, LeBlanc ML, Rimsza LM, Cerhan JR, Habermann TM, Link BK, Maurer MJ, Slager SL, Persky DO, Miller TP, Fisher RI, Ambrosone CB, Briehl MM.

Am J Hematol. 2014 Jun;89(6):639-45. doi: 10.1002/ajh.23709. Epub 2014 Apr 12.


The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies.

Lee K, Briehl MM, Mazar AP, Batinic-Haberle I, Reboucas JS, Glinsmann-Gibson B, Rimsza LM, Tome ME.

Free Radic Biol Med. 2013 Jul;60:157-67. doi: 10.1016/j.freeradbiomed.2013.02.003. Epub 2013 Feb 14.


Mitochondrial adaptations to oxidative stress confer resistance to apoptosis in lymphoma cells.

Wilkinson ST, Tome ME, Briehl MM.

Int J Mol Sci. 2012;13(8):10212-28. doi: 10.3390/ijms130810212. Epub 2012 Aug 16.


Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.

Sertel S, Tome M, Briehl MM, Bauer J, Hock K, Plinkert PK, Efferth T.

PLoS One. 2012;7(5):e35584. doi: 10.1371/journal.pone.0035584. Epub 2012 May 10.


Lymphoma cells with increased anti-oxidant defenses acquire chemoresistance.

Tome ME, Frye JB, Coyle DL, Jacobson EL, Samulitis BK, Dvorak K, Dorr RT, Briehl MM.

Exp Ther Med. 2012 May;3(5):845-852. Epub 2012 Feb 14.


Manganese porphyrin, MnTE-2-PyP5+, Acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells.

Jaramillo MC, Briehl MM, Crapo JD, Batinic-Haberle I, Tome ME.

Free Radic Biol Med. 2012 Apr 15;52(8):1272-84. doi: 10.1016/j.freeradbiomed.2012.02.001. Epub 2012 Feb 11.


Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells.

Tome ME, Jaramillo MC, Briehl MM.

Free Radic Biol Med. 2011 Dec 1;51(11):2048-59. doi: 10.1016/j.freeradbiomed.2011.09.002. Epub 2011 Sep 10.


Increased cytochrome c correlates with poor survival in aggressive lymphoma.

Wilkinson ST, Johnson DB, Tardif HL, Tome ME, Briehl MM.

Oncol Lett. 2010 Mar;1(2):227-230.


Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolide.

Skalska J, Brookes PS, Nadtochiy SM, Hilchey SP, Jordan CT, Guzman ML, Maggirwar SB, Briehl MM, Bernstein SH.

PLoS One. 2009 Dec 2;4(12):e8115. doi: 10.1371/journal.pone.0008115.


Increased manganese superoxide dismutase expression or treatment with manganese porphyrin potentiates dexamethasone-induced apoptosis in lymphoma cells.

Jaramillo MC, Frye JB, Crapo JD, Briehl MM, Tome ME.

Cancer Res. 2009 Jul 1;69(13):5450-7. doi: 10.1158/0008-5472.CAN-08-4031. Epub 2009 Jun 23.


Modulation of human glutathione s-transferases by polyphenon e intervention.

Chow HH, Hakim IA, Vining DR, Crowell JA, Tome ME, Ranger-Moore J, Cordova CA, Mikhael DM, Briehl MM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1662-6.


Glucose 6-phosphate dehydrogenase overexpression models glucose deprivation and sensitizes lymphoma cells to apoptosis.

Tome ME, Johnson DB, Samulitis BK, Dorr RT, Briehl MM.

Antioxid Redox Signal. 2006 Jul-Aug;8(7-8):1315-27.


A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.

Tome ME, Johnson DB, Rimsza LM, Roberts RA, Grogan TM, Miller TP, Oberley LW, Briehl MM.

Blood. 2005 Nov 15;106(10):3594-601. Epub 2005 Aug 4.


Molecular modes of action of cantharidin in tumor cells.

Efferth T, Rauh R, Kahl S, Tomicic M, Böchzelt H, Tome ME, Briehl MM, Bauer R, Kaina B.

Biochem Pharmacol. 2005 Mar 1;69(5):811-8. Epub 2005 Jan 21.


Increasing the antioxidant defense in WEHI7.2 cells results in a more tumor-like metabolic profile.

Tome ME, Briehl MM, Lutz NW.

Int J Mol Med. 2005 Mar;15(3):497-501.


Role of antioxidant genes for the activity of artesunate against tumor cells.

Efferth T, Briehl MM, Tome ME.

Int J Oncol. 2003 Oct;23(4):1231-5.


Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells.

Dvorakova K, Payne CM, Tome ME, Briehl MM, Vasquez MA, Waltmire CN, Coon A, Dorr RT.

Mol Cancer Ther. 2002 Jan;1(3):185-95.


Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression.

Gupta A, Butts B, Kwei KA, Dvorakova K, Stratton SP, Briehl MM, Bowden GT.

Cancer Lett. 2001 Nov 28;173(2):115-25.


Induction of mitochondrial changes in myeloma cells by imexon.

Dvorakova K, Waltmire CN, Payne CM, Tome ME, Briehl MM, Dorr RT.

Blood. 2001 Jun 1;97(11):3544-51.


Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth.

Tome ME, Baker AF, Powis G, Payne CM, Briehl MM.

Cancer Res. 2001 Mar 15;61(6):2766-73.


Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon.

Dvorakova K, Payne CM, Tome ME, Briehl MM, McClure T, Dorr RT.

Biochem Pharmacol. 2000 Sep 15;60(6):749-58.


Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase.

Siemankowski LM, Morreale J, Butts BD, Briehl MM.

Cancer Res. 2000 Jul 1;60(13):3638-44.


Antioxidant defenses in the TNF-treated MCF-7 cells: selective increase in MnSOD.

Siemankowski LM, Morreale J, Briehl MM.

Free Radic Biol Med. 1999 Apr;26(7-8):919-24.


Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo.

Baker A, Payne CM, Briehl MM, Powis G.

Cancer Res. 1997 Nov 15;57(22):5162-7.


Modulation of antioxidant defenses during apoptosis.

Briehl MM, Baker AF, Siemankowski LM, Morreale J.

Oncol Res. 1997;9(6-7):281-5. Review.


Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.

Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, Powis G.

Cancer Res. 1996 Dec 15;56(24):5765-70.


Modulation of the antioxidant defence as a factor in apoptosis.

Briehl MM, Baker AF.

Cell Death Differ. 1996 Jan;3(1):63-70.


Downregulation of the antioxidant defence during glucocorticoid-mediated apoptosis.

Briehl MM, Cotgreave IA, Powis G.

Cell Death Differ. 1995 Jan;2(1):41-6.


Elevated glutathione S-transferase gene expression is an early event during steroid-induced lymphocyte apoptosis.

Flomerfelt FA, Briehl MM, Dowd DR, Dieken ES, Miesfeld RL.

J Cell Physiol. 1993 Mar;154(3):573-81.


Transcriptional analyses of steroid-regulated gene networks.

Briehl MM, Flomerfelt FA, Wu XP, Miesfeld RL.

Mol Endocrinol. 1990 Feb;4(2):287-94.


Supplemental Content

Loading ...
Support Center